Bessemer Group Inc Jazz Pharmaceuticals PLC Transaction History

Bessemer Group Inc

$61.3 Billion
Q4 2024

A detailed history of Bessemer Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bessemer Group Inc holds 26,932 shares of JAZZ stock, worth $3.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,932

Previous 26,840 0.34%

Holding current value

$3.78 Million

Previous $2.99 Million 10.9%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$107.32 - $127.74 $9,873 - $11,752	92 Added 0.34%	26,932 $3.32 Million
Q3 2024 Nov 12, 2024	BUY	$100.57 - $116.37 $2.69 Million - $3.11 Million	26,739 Added 26474.26%	26,840 $2.99 Million
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $4,261 - $4,878	41 Added 68.33%	101 $11,000
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $450,392 - $519,130	-3,910 Reduced 98.49%	60 $8,000
Q4 2023 Feb 09, 2024	SELL	$114.26 - $136.0 $45,589 - $54,264	-399 Reduced 9.13%	3,970 $488,000
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $4,392 - $5,231	-36 Reduced 0.82%	4,369 $565,000
Q2 2023 Aug 10, 2023	BUY	$122.5 - $147.16 $4,287 - $5,150	35 Added 0.8%	4,405 $545,000
Q1 2023 May 10, 2023	BUY	$133.98 - $160.47 $133 - $160	1 Added 0.02%	4,370 $639,000
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $7,004 - $8,631	54 Added 1.25%	4,369 $696,000
Q3 2022 Nov 09, 2022	BUY	$126.59 - $161.18 $29,495 - $37,554	233 Added 5.71%	4,315 $575,000
Q2 2022 Aug 10, 2022	SELL	$141.59 - $168.66 $28,601 - $34,069	-202 Reduced 4.72%	4,082 $637,000
Q1 2022 May 12, 2022	BUY	$129.64 - $160.7 $162,179 - $201,035	1,251 Added 41.25%	4,284 $667,000
Q4 2021 Jan 27, 2022	BUY	$119.87 - $145.67 $113,516 - $137,949	947 Added 45.4%	3,033 $386,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $3,215 - $4,619	25 Added 1.21%	2,086 $272,000
Q2 2021 Aug 06, 2021	SELL	$160.2 - $186.42 $54,628 - $63,569	-341 Reduced 14.2%	2,061 $366,000
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $73,593 - $85,015	490 Added 25.63%	2,402 $394,000
Q4 2020 Feb 09, 2021	BUY	$140.71 - $165.05 $22,372 - $26,242	159 Added 9.07%	1,912 $316,000
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $184,871 - $252,659	1,753 New	1,753 $250,000
Q2 2019 Jul 19, 2019	SELL	$125.55 - $144.48 $878 - $1,011	-7 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$121.81 - $142.95 $1,339 - $1,572	-11 Reduced 61.11%	7 $1,000
Q3 2018 Nov 06, 2018	BUY	$161.01 - $180.57 $2,898 - $3,250	18 New	18 $3,000
Q1 2018 May 10, 2018	SELL	$135.59 - $157.16 $10,982 - $12,729	-81 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$142.62 - $155.6 $11,552 - $12,603	81	81 $12,000

Others Institutions Holding JAZZ

# of Institutions

544

Shares Held

59M

Call Options Held

125K

Put Options Held

58.4K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.79B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Jazz Pharmaceuticals PLC Transaction History